Pursuant to Section 1 (3b) of the Austrian Medicines Act (AMG) or pursuant to Section 2 (5) of the Veterinary Medicinal Products Act (TAMG), persons wishing to place a product on the market may submit an application to the Federal Office for Safety in Health Care (BASG) to determine whether this product falls within the definition of a medicinal product or a veterinary medicinal product. This is a chargeable entry in accordance with the Fees Ordinance of the Federal Office as amended. Within the framework of this determination, an expert opinion is drawn up together with an official decision.

The application must be sent preferably by e-mail using the completed form F_I612 and the necessary documents.

Within the scope of this procedure, pursuant to Section 1 (3b) AMG or Section 2 (5) TAMG, the BASG may obtain an expert opinion of the Delineation Commission pursuant to Section 49a AMG or Section 2 (5) TAMG.

Alternatively, persons wishing to place a product on the market can submit an informal enquiry to BASG by e-mail, which is answered by e-mail without a formal expert opinion and without notification. A fee (at an hourly rate) will be charged for the processing time in accordance with Section 8 (2) Fees Ordinance of the Federal Office .

The Delineation Advisory Board (AGBR) is an organ established at the Federal Ministry of Social Affairs, Health, Care and Consumer Protection (BMSGPK) (Section 49a AMG). Its task is the preparation of expert opinions on the delineation of medicinal products from other products, on behalf of the BMSGPK or the BASG.

According to the "Verordnung der Bundesministerin für Gesundheit und Frauen, mit der Geschäftsordnung des Abgrenzungsbeirats erlassen wird", BGBl. II Nr. 354/2006 (Ordinance of the Federal Minister of Health and Women on the Rules of Procedure of the Delineation Advisory Board), expert opinions of the Delineation Advisory Board together with the reasons for the decision are to be published on the Internet on the website of the BASG.

The delineation commission in accordance with Section 60 AMG advises the Federal Ministry of Social Affairs, Health, Care and Consumer Protection (BMSGPK) on which medicinal products may only be dispensed in pharmacies and which may also be distributed by drugstores.

The Federal Office for Safety in Health Care carries out qualifications of medical devices exclusively based on § 10 Medical Devices Act 2021 (MPG 2021), BGBl. I 122/2021, as amended. We would like to point out that a fee-based application for qualification/classification can only be made by a manufacturer or authorised representative legally based in Austria.

Further information: Borderline and classification

Regarding the costs, please note the current Fee Regulation (section XI).